Onyx CEO Tony Coles will score $58M on Amgen deal

When Amgen and Onyx Pharmaceuticals close their buyout deal later this year, CEO Tony Coles will walk away from the table with $57.5 million in cash on its way. And if Coles loses his job at the combi…
Read the full story: FiercePharma News